美股新聞 標題聯播 · 近 24 小時 269 則 · 25 個來源 · 最新 9/20 07:24
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · TECH近 30 天 8 則 · 第 1 / 1 頁
- Bio Techne (TECH) And The Valuation Case Behind Its Recent Rebound
- Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?
- Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others
- Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
- Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks
- 1 Surging Stock for Long-Term Investors and 2 That Underwhelm
- 1 Profitable Stock to Own for Decades and 2 We Turn Down
- Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?
- Is Wall Street Bullish or Bearish on Bio-Techne Stock?
- 3 High-Flying Stocks We Approach with Caution
- TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises
- Bio-Techne Corrects Dividend Announcement
- Techne (TECH) Q4 Earnings Meet Estimates
- Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales
- Bio-Techne Declares Dividend
- Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
- Is Bio-Techne (TECH) Above Fair Value After A 44% Return?
- JAZZ vs. TECH: Which Stock Is the Better Value Option?
- Investors’ Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases
- 2 S&P 500 Stocks to Keep an Eye On and 1 We Turn Down
- 1 Healthcare Stock Worth Your Attention and 2 We Question
- Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake?
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。